In multivariate analysis, tumor size, lymph node stage, hormone receptor negativity, high histologic grade, high Ki-67 and low HER2 level were linked to inferior DFS for the entire enrolled patients (Table 2). The gene discussed is ERBB2; the disease is neoplasm.